Photocatalytic study of organosilane-modified zinc oxide nanoparticles
Ovidius University Annals of Chemistry · 2015
DOI: 10.1515/auoc-2015-0012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ovidius University Annals of Chemistry, 2015. Verfasst von Aurel Tăbăcaru und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0).
Abstract (Originalsprache)
In our recent studies, we have investigated the tunability of optical properties of zinc oxide nanoparticles (ZnO NPs) through surface modification with organosilane surfactants. In the present paper, the effect of ZnO NPs modified with variable amount of 3-(trimethoxysilyl)propylmethacrylate (MPS) surfactant was investigated toward the photocatalytic degradation of methylene blue (MB), using two different UV light sources emitting at 254 nm and 365 nm. While the maximum photodegradation efficiency of 63% was reached by ZnO NPs loaded with the highest concentration of MPS upon exposure at 254 nm, in the case of UV exposure at 365 nm an opposite photodegradation trend was observed. Actually, a significant photodegradation efficiency of 95% was recorded by the unmodified ZnO, followed by ZnO NPs modified with 2% MPS for which the photodegradation efficiency amounted to 80%, thus highlighting their best photocatalytic performance.
Zitieren
APA
Tăbăcaru, A., Buşilă, M., Pleşcan, V. G., & Muşat, V. (2015). Photocatalytic study of organosilane-modified zinc oxide nanoparticles. Ovidius University Annals of Chemistry. https://doi.org/10.1515/auoc-2015-0012
Vancouver
Tăbăcaru A, Buşilă M, Pleşcan VG, Muşat V. Photocatalytic study of organosilane-modified zinc oxide nanoparticles. Ovidius University Annals of Chemistry. 2015. doi:10.1515/auoc-2015-0012
BibTeX
@article{Tbcaru2015,
author = {Tăbăcaru, Aurel and Buşilă, Mariana and Pleşcan, Viorica (Ghisman) and Muşat, Viorica},
title = {Photocatalytic study of organosilane-modified zinc oxide nanoparticles},
journal = {Ovidius University Annals of Chemistry},
year = {2015},
doi = {10.1515/auoc-2015-0012}
}
EUVIMED